RX3341 (Baxdela 450 mg)
Generic Name: delafloxacin
Pill with imprint RX3341 is Beige, Capsule-shape and has been identified as Baxdela 450 mg. It is supplied by Melinta Therapeutics.
Baxdela is used in the treatment of pneumonia; skin and structure infection and belongs to the drug class quinolones. Baxdela 450 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RX3341
Baxdela
- Generic Name
- delafloxacin
- Imprint
- RX3341
- Strength
- 450 mg
- Color
- Beige
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Quinolones
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Melinta Therapeutics
- National Drug Code (NDC)
- 70842-0101
- Inactive Ingredients
-
microcrystalline cellulose,
povidone k30,
sodium bicarbonate,
citric acid anhydrous,
water
Note: Inactive ingredients may vary.
More about Baxdela (delafloxacin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: quinolones
- FDA Alerts (1)
- FDA Approval History
Consumer resources
- Patient Information
- Baxdela (Advanced Reading)
- Baxdela Intravenous (Advanced Reading)
- Baxdela (Delafloxacin Injection)
- Baxdela (Delafloxacin Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.